Park JS, Kwon J, Choi HJ, Lee C
GLP-1 RA and atrial fibrillation in the cardiovascular outcome trials
Upcoming Book McCall reveals that they have sold a book proposal to Penguin Random House, with a release date set for spring 2027
Hers/Hims offers brand-name GLP-1s, as well as generic liraglutide, which is much more affordable and was approved by the FDA for weight loss in 2025
Other Ways to Access GLP-1 Treatments If your insurance appeals dont work out, there are still alternative ways to access GLP-1 treatments
The programme also included a long-term safety trial, trials to evaluate the use of orally administered semaglutide in individuals with moderate renal impairment and as add-on to insulin as well as a cardiovascular outcome trial (CVOT) to evaluate the CV safety profile